3B BlackBio Dx Limited Promoters Declare No Share Encumbrance for FY2026
3B BlackBio Dx Limited has filed its mandatory annual disclosure under SEBI Takeover Regulations 31(4), confirming that promoters maintained no encumbrance or pledge of shares during FY2026. The declaration was submitted by promoter Nikhil Kuber Dubey on behalf of the entire promoter group, demonstrating clean shareholding structure and regulatory compliance. This transparency measure reinforces the company's commitment to corporate governance standards and investor protection requirements.

*this image is generated using AI for illustrative purposes only.
3B BlackBio Dx Limited has submitted its annual regulatory disclosure to BSE Limited, confirming that its promoter group maintained clean shareholding throughout the financial year ended March 31, 2026. The disclosure, filed under SEBI Takeover Regulations, demonstrates the company's commitment to regulatory compliance and transparency.
Regulatory Compliance Declaration
The disclosure was filed by Nikhil Kuber Dubey, a key promoter of the company, who submitted the declaration on behalf of the entire promoter and promoter group along with persons acting in concert. Company Secretary and Compliance Officer Navneet Kaur (ACS No.29130) facilitated the filing to BSE Limited on April 4, 2026.
| Filing Details: | Information |
|---|---|
| Regulation: | SEBI Takeover Regulations 31(4) |
| Financial Year: | Ended March 31, 2026 |
| Filing Date: | April 4, 2026 |
| Promoter Representative: | Nikhil Kuber Dubey |
| Company Secretary: | Navneet Kaur (ACS No.29130) |
Share Encumbrance Status
The promoter group has declared that no encumbrance or pledge of shares was made directly or indirectly during the financial year ended March 31, 2026. This declaration covers all members of the promoter and promoter group, including persons acting in concert with the company.
The clean shareholding status indicates that promoters have maintained full ownership rights over their shareholding without creating any security interests or pledges against their equity stakes. This transparency measure is mandated under SEBI regulations to protect investor interests and maintain market integrity.
Corporate Governance Framework
The filing represents part of the company's ongoing compliance with SEBI's substantial acquisition and takeover regulations. These annual disclosures ensure that stakeholders remain informed about any changes in promoter shareholding patterns and encumbrance status.
| Compliance Aspect: | Status |
|---|---|
| Share Encumbrance: | Nil |
| Share Pledge: | Nil |
| Regulatory Compliance: | Complete |
| Disclosure Timeline: | Within prescribed limits |
The company operates from its registered office at 7C, Industrial Area, Govindpura, Bhopal-462023, and the disclosure has been copied to the Chairman of the Audit Committee as part of internal governance protocols. This filing reinforces the company's commitment to maintaining transparent corporate governance standards and regulatory compliance.
Historical Stock Returns for 3B BlackBio DX
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.51% | +7.64% | -3.20% | -14.47% | -28.09% | +266.16% |
Will 3B BlackBio Dx consider raising capital through promoter share pledging in the upcoming financial year to fund expansion plans?
How might the company's clean shareholding status impact its credit rating and ability to secure institutional funding for future projects?
What strategic acquisitions or partnerships could 3B BlackBio Dx pursue now that promoter shares remain unencumbered?


































